| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |